Rion Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Rion has been growing earnings at an average annual rate of 8.1%, while the Medical Equipment industry saw earnings growing at 7.8% annually. Revenues have been growing at an average rate of 5.2% per year. Rion's return on equity is 8.6%, and it has net margins of 9.7%.
Belangrijke informatie
8.1%
Groei van de winst
8.0%
Groei van de winst per aandeel
Medical Equipment Groei van de industrie | 7.8% |
Inkomstengroei | 5.2% |
Rendement op eigen vermogen | 8.6% |
Nettomarge | 9.7% |
Volgende winstupdate | 25 Nov 2024 |
Opbrengsten en kosten
Hoe Rion geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 26,665 | 2,591 | 8,945 | 889 |
30 Jun 24 | 26,068 | 2,369 | 8,928 | 889 |
31 Mar 24 | 25,726 | 2,652 | 8,618 | 889 |
31 Dec 23 | 25,399 | 2,511 | 8,461 | 887 |
30 Sep 23 | 25,171 | 2,452 | 8,411 | 887 |
30 Jun 23 | 24,698 | 2,295 | 8,177 | 887 |
31 Mar 23 | 23,868 | 1,799 | 7,944 | 887 |
31 Dec 22 | 23,489 | 1,982 | 7,661 | 926 |
30 Sep 22 | 23,218 | 1,991 | 7,535 | 926 |
30 Jun 22 | 22,949 | 2,052 | 7,447 | 926 |
31 Mar 22 | 22,635 | 2,229 | 7,347 | 926 |
31 Dec 21 | 21,850 | 1,993 | 7,373 | 764 |
30 Sep 21 | 21,353 | 1,758 | 7,344 | 764 |
30 Jun 21 | 21,338 | 1,697 | 7,404 | 764 |
31 Mar 21 | 20,466 | 1,636 | 7,243 | 764 |
31 Dec 20 | 20,698 | 1,644 | 7,255 | 902 |
30 Sep 20 | 20,304 | 1,501 | 7,334 | 902 |
30 Jun 20 | 20,574 | 1,632 | 7,440 | 902 |
31 Mar 20 | 21,465 | 1,779 | 7,674 | 902 |
31 Dec 19 | 21,435 | 1,960 | 7,516 | 1,118 |
30 Sep 19 | 21,875 | 2,208 | 7,524 | 1,118 |
30 Jun 19 | 21,503 | 2,073 | 7,541 | 1,118 |
31 Mar 19 | 21,289 | 2,002 | 7,572 | 1,118 |
31 Dec 18 | 21,023 | 1,905 | 7,597 | 1,126 |
30 Sep 18 | 20,765 | 1,934 | 7,473 | 1,126 |
30 Jun 18 | 20,549 | 1,956 | 7,403 | 1,126 |
31 Mar 18 | 20,350 | 1,887 | 7,321 | 1,126 |
31 Dec 17 | 20,042 | 1,939 | 7,219 | 1,099 |
30 Sep 17 | 19,581 | 1,678 | 7,167 | 1,099 |
30 Jun 17 | 19,484 | 1,574 | 7,157 | 1,099 |
31 Mar 17 | 19,194 | 1,408 | 7,218 | 1,099 |
31 Dec 16 | 19,003 | 1,404 | 6,908 | 1,165 |
30 Sep 16 | 18,900 | 1,457 | 6,836 | 1,165 |
30 Jun 16 | 18,721 | 1,497 | 6,607 | 1,165 |
31 Mar 16 | 18,859 | 1,594 | 6,479 | 1,165 |
31 Dec 15 | 19,114 | 1,457 | 6,729 | 1,060 |
30 Sep 15 | 18,972 | 1,421 | 6,706 | 1,060 |
30 Jun 15 | 18,978 | 1,480 | 6,708 | 1,060 |
31 Mar 15 | 18,758 | 1,427 | 6,621 | 1,060 |
31 Dec 14 | 18,773 | 1,496 | 6,552 | 1,067 |
30 Sep 14 | 18,662 | 1,392 | 6,539 | 1,067 |
30 Jun 14 | 18,494 | 1,258 | 6,557 | 1,067 |
31 Mar 14 | 18,510 | 1,316 | 6,500 | 1,067 |
31 Dec 13 | 17,874 | 1,196 | 6,527 | 913 |
Kwaliteitswinsten: 6823 has high quality earnings.
Groeiende winstmarge: 6823's current net profit margins (9.7%) are lower than last year (9.7%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 6823's earnings have grown by 8.1% per year over the past 5 years.
Versnelling van de groei: 6823's earnings growth over the past year (5.7%) is below its 5-year average (8.1% per year).
Winst versus industrie: 6823 earnings growth over the past year (5.7%) did not outperform the Medical Equipment industry 5.7%.
Rendement op eigen vermogen
Hoge ROE: 6823's Return on Equity (8.6%) is considered low.